Staying on top of regulatory changes, new technical innovations, and industry-disrupting competitors has never been harder. With so much information available, how do you ensure you have the insight you need to drive your business forward and seize opportunities before the competition?
Our regulatory and scientific experts are here to help you stay up to speed with new trends and research. Let them share their expertise and insight so you can focus on building your business.
At Broughton, our consultants have deep industry knowledge across all the elements required for a PMTA. We guide you through and generate the required data, to ensure that FDA finds your applications strong and compelling.
Click to download
An overview of the Tobacco Products Directive and Tobacco-Related Products Regulations. Get the straightforward answers you’re looking for when it comes to TPD and TRPR analysis.
Click to download
Looking to take your ENDS products to new markets? Compare the differences and get the pros and cons between products with EU Tobacco Products Directive (TPD) notification and products with an EU medicinal product license in our free download.
Click to download
We help companies of all sizes through the product lifecycle stages, from concept innovation, product realization, and regulatory submission to post marketing surveillance.
Click to download
The MHRA is now a stand-alone body issuing national authorizations only. This infographic outlines the routes to a Pharmaceutical Marketing Authorization in the UK.
Click to download
The evaluation of extractables and leachables (E&L) is an essential component of the pharmaceutical development process.
Click to download
Our team of in-house toxicologists reviews and evaluates toxicological data on a wide range of chemicals to produce independent expert opinions on risk assessment. We then advise on the strategies to mitigate or reduce those risks to protect corporate reputation and public health.
Click to download
Developing and commercializing new inhaled drug products, requires huge energy and deep scientific understanding. This level of resource and subject matter expertise can be difficult to maintain inside your business, and that is where we can help.
Click to download
As the holder of a UK Home Office controlled drug license, we offer a wide range of services for cannabinoids including UK and EU Novel Food Application scientific consultancy and analytical testing support.
Click to download
Our product development and regulatory experts can help you meet expectations at key milestones in your product development project to better inform decision making and investment choices.
Click to download
We believe that the sectors we work within expect a continually improving service where we constantly strive to improve processes and Quality.
Click to download
Learn about six easy-to-spot packaging violations that could indicate a vape is illicit and shouldn't be on sale in the UK and EU.
Click to download
In this whitepaper, Broughton discusses the susceptibility of cannabinoids to degrade and summarizes the main degradation pathways of the primary cannabinoid products on the market; tetrahydrocannabinol (THC) and Cannabidiol (CBD).
Click to download
Dr. Nveed Chaudhary Chief Scientific and Regulatory Officer, Paul Hardman Managing Consultant Chemistry and Manufacturing Controls, and, Libby Clarke Managing Consultant Toxicology share their thoughts on how to reduce costs and protect timelines while continuing to innovate.
Click to download
Broughton summarises the regulatory pathways available for cannabinoid products in the UK market and the legal requirements for each potential market route.
Click to download
To develop cannabis products that can both enhance the quality of life of cannabis users and comply with current and future regulations, we believe that fi rst we need to understand what cannabis is, how people use it, and how it affects the human body and mind. This white paper aims to provide essential but concise information about these areas, supported by scientific evidence.
Click to download
Since their introduction in 1956, pressurised metered dose inhalers (pMDIs) have become the dominant treatment choice for patients suffering from common respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). However, unbeknown to most patients and many doctors, pMDIs account for 3.9% of NHS’s annual carbon emissions. 1Here we will discuss how formulation changes might be the answer to the pMDI-related sustainability problem.
Click to download
As scientists work to develop new analytical methods for delivering veterinary medicines (often referred to as animal health products) to market, ....
This year’s RDD Europe conference was held between the 2nd and 5th of May in Antibes, France.
The Food Standards Agency (FSA) in the UK has recently approved several applications for novel food products that contain cannabidiol (CBD) derived ....
This event will focus on analytical science, medical cannabis, cultivation, and psychedelics. The conference will take place in Portland, USA
Start date: 2023-04-20
Location: Portland, USA
Visit Event Website
Making Pharmaceuticals is a leading UK Pharmaceutical Conference covering six different industry zones. Our Business Development Managers Jay Russell and Luke Williams will be attending.
Start date: 2023-04-25
Location: Coventry, UK
Visit Event Website
This event focuses on the respiratory industry with prominent researchers and key opinion leaders providing actionable insights relevant to science, regulation, business and clinical practice. Chief Commercial Officer, Andy Mooney and Managing Consultant, Paul Hardman will be attending the event.
Start date: 2023-05-02
Location: Nice, France
Visit Event WebsiteArrange a meeting with a scientific or regulatory expert to discuss your project and learn how we can help accelerate your product to market to maximize your success.
